Lund

Now, it turns out that we have, um, a lot of different ways we can show up in the world, of course.

And one of my, uh, great colleagues, a woman named, uh, Kim Nicholas at, uh, Lund University in Sweden, she's a professor there, um, at, at Lund in Sweden.

Uh, she used to be a student of mine years ago in her master's degree, but then she went and got her PhD at Stanford, is just wickedly smart, amazing person.

She created a kind of a guide for individual climate action that's really grounded in the research.

Last time on the podcast we had conversations with Theolife president and CEO Thomas Ruggia about myopia and with Brian McClellan and William Matsui about their prostate cancer research.

This week we visit Sweden, although not literally, to talk to a company in Lund and that is Asgard Therapeutics and its co-founder and CEO, Christiana Pires, about in vivo direct cell reprogramming for cancer immunotherapy.

And we chat about clinical diagnostics with Miriam Sefta, CEO of Wave, and that is spelt W-A-I-V, and that's because it's an AI company.

If you do have news or suggestions for who should be on the podcast or indeed any other suggestions or comments, please do get in touch at jim at deeptechdigest.com, which is also the address you can use if you're interested in advertising with us, sponsoring a podcast episode or for event coverage.

And this was published in 2018 in Science Immunology.

And at the same point, we created the company Asger Therapeutics because we were, all the three of us, very passionate on taking our technology outside of the lab and developing a new drug that we could bring to patients and give our contribution to society.

And so the company started in December 2018, and it's a spin-out from Lund University in Sweden, because along the way, the three Portuguese came to Sweden to do research here at Lund University.

So we were working together at the time.

Save big money at Menards.

[upbeat music] Hello and welcome to another episode of No Such Thing As A Fish, a weekly podcast, this week coming to you live from the Lund Comedy Festival in Sweden.

[cheering] My name is Dan Schreiber.

I am sitting here with Anna Teshinsky, Andrew Hunter Murray, and James Harkin.

And once again, we have gathered round the microphones with our four favorite facts from the last seven days, and in no particular order, here we go.

Starting with fact number one, and that is my fact.

My fact this week is that in many Indian languages, Lund University means penis university.

[laughs]

This will be our third time speaking at this conference.

And actually, just months ago, I visited their headquarters in Lund, Sweden, which is in the southern part of Sweden.

And they've had a busy summer of releasing data.

And so we're going to get caught up on that.

It's purely, you know, I've got so much trust and confidence in the whole team.

Both, you know, the Cambridge guys and girls, as well as especially the Lund team.

team here

who

I'm based in Malmo, Sweden.

I'm a stroke neurologist trained here and also a professor in neurology at Lund University.

I have a longstanding interest in acute stroke treatment.

especially taking part in organizing RCTs, but also in the last years, a lot of epidemiological studies to find hopefully new associations and ways to treat and prevent stroke.

Even when they were legal, they were still sold discreetly because these were not things that I think were widely acceptable or understood in society.

There was even a pig intestine condom from 1640 that was excavated in Lund, Sweden, which I think is really fascinating.

So vulcanized rubber was created in 1839, and this made condoms widely available.

So by the 1870s, condoms were sold openly through catalogs, pharmacies, and dry goods stores.